- Boosters Halve Severe COVID-19 Risk: A large study led by the University of Bristol and University of Oxford found that booster vaccines reduced the risk of COVID-19 hospitalization and death by about 50% among adults aged 50 and older.
- Moderna and Pfizer Boosters Perform Similarly: Researchers analyzing health records through NHS England found comparable protection from boosters produced by Moderna and Pfizer-BioNTech, though protection was strongest in the first 70 days and gradually declined over time.
- Real-World Evidence Confirms Booster Effectiveness: Data from over 3 million adults showed significantly lower hospitalization and death rates among boosted individuals, reinforcing booster vaccination as a critical tool to prevent severe COVID-19 outcomes in older populations.
Fair Use Notice
UNMC Global Center for Health Security staff curate publicly available news and information for educational and informational purposes. Brief excerpts of published articles may be displayed under principles of Fair Use, with credit and links provided to the source publications. All copyrights remain the property of their respective owners.